Free tool
Drug literature search
Last checked: Nov 20, 2026Source: PubMed, Europe PMC, OpenAlex
555 results in Europe PMC
PubMed plus preprints and full-text open access papers. Showing the first 25. Limited to clinical trials, meta-analyses and systematic reviews.
- Is Milk Elimination Enough? A Systematic Review and Meta-Analysis of One-Food Elimination Diet in Eosinophilic Esophagitis.
Tsaggaridou S, Pitsios C. · Med Sci (Basel) · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
- Dupilumab normalizes the eosinophilic esophagitis disease transcriptome.
Lim WK, Wipperman MF, Rothenberg ME, Collins MH, Hamon SC, Chehade M, Spergel JM, Gayvert KM, Ehmann PJ, Horowitz JE, Farrell AB, Dellon ES, Maloney J, Radin A, Louisias M, Wolfe K, Akinlade B, Ajithdoss DK, Herman G, Yancopoulos GD, Hamilton JD. · J Allergy Clin Immunol · 2026 · cited 2 timesresearch support, non-u.s. gov't, randomized controlled trial
- Efficacy and Safety of Dupilumab in Eosinophilic Esophagitis: A Systematic Review and Meta-Analysis.
Khalaf R, Ton That A, Tardio N, Afif W, Schneider R, Ben-Shoshan M. · Int Arch Allergy Immunol · 2026 · cited 0 timesOpen accesssystematic review, review-article
- Dupilumab improves clinical outcome assessments in children with eosinophilic esophagitis in a randomized phase 3 study.
Chehade M, Spergel JM, Oliva S, Dellon ES, Ashok D, Rothenberg ME, Liu R, Louisias M, Radin A, Tilton ST, McCann E. · BMC Gastroenterol · 2026 · cited 0 timesOpen accessclinical trial, phase iii, multicenter study
- Effect of budesonide oral suspension on dysphagia and esophageal inflammation in eosinophilic esophagitis: a systematic review and meta-analysis.
López Delgado DS, Narváez CA, Chapues-Andrade GL, Matus-Hernández MA, González-Hidalgo V, Diaz-Gonzales G, Rivera-Lozada O, Barboza JJ. · Front Immunol · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
- Comparative efficacy and safety of dupilumab and swallowed topical corticosteroid formulations in eosinophilic esophagitis: A systematic review and network meta-analysis of randomized controlled trials.
Arsalan M, Sawaira F, Shah S, Bhatti F, Mustafa FE, Antar AS, Shahzaib M, Majid A, Hassan T, Zubair T, Yasir M, Junaid M, Ullah F, Shahab SH. · Medicine (Baltimore) · 2026 · cited 0 timesOpen accesscomparative study, systematic review
- Eosinophilic Esophagitis following Oral Immunotherapy: A Systematic Review and Meta-Analysis.
Khalaf R, Fields M, Fields E, Tardio N, Afif W, Schneider R, Ben-Shoshan M. · Int Arch Allergy Immunol · 2026 · cited 2 timesOpen accesssystematic review, review-article
- Dupilumab Improves Endoscopic Features in Adult and Adolescent Patients with Eosinophilic Esophagitis: Post Hoc Analysis of LIBERTY EoE TREET Study.
Dellon ES, Collins MH, Peterson K, Sun X, Raphael BP, Louisias M, Radin A. · Clin Transl Gastroenterol · 2026 · cited 0 timesOpen accessclinical trial, phase iii, multicenter study
- Monoclonal Antibodies for Eosinophilic Esophagitis and Gastritis: A Systematic Review and Meta-Analysis.
Irfan Q, Zaidi SMM, Alvi MH, Mustafa A, Hayat BA, Usman L, Danish R, Ahmad SA. · J Clin Gastroenterol · 2026 · cited 0 timesmeta-analysis, systematic review
- Pathogenesis of Eosinophilic Esophagitis: A PRISMA-Based Systematic Review of Genetic, Immunological, and Molecular Drivers.
Lachowicz J, Lachowicz J, Di Petrillo A, Floris S, Favale A, Lutzu N, Onali S, Fantini MC. · Clin Transl Gastroenterol · 2026 · cited 1 timesOpen accesssystematic review, review-article
- Cendakimab in Adults and Adolescents with Eosinophilic Esophagitis.
Dellon ES, Charriez CM, Zhang S, Falk GW, Oliva S, Ma C, Siffledeen J, Schroeder S, Philpott H, Vanuytsel T, Abe Y, Li K, Zema CL, Venkatasamy A, Yeshokumar AK, Oh YS, Schoepfer A. · NEJM Evid · 2025 · cited 11 timesclinical trial, phase iii, multicenter study
- Population Pharmacokinetics of Dupilumab in Adults, Adolescents, and Children With Eosinophilic Esophagitis.
Nguyen JH, Chehade M, Dellon ES, Radin A, Chittenden J, Kamal MA, Louisias M, Xu C, Kosloski MP. · Clin Pharmacol Ther · 2026 · cited 0 timesOpen accessclinical trial, phase iii, research support, non-u.s. gov't
- Efficacy of Biological and Steroid Therapies in Adolescent and Adult Patients With Eosinophilic Esophagitis: A Systematic Review and Network Meta-Analysis With Meta-Regression.
Al Hayek M, Lucendo AJ, Savarino EV, Barberio B, Gyawali CP, Chan WW, Visaggi P, Najah Q, Yadlapati R, McCoul ED, Elhadi M, Laine L. · Clin Gastroenterol Hepatol · 2026 · cited 2 timessystematic review, network meta-analysis
- Comprehensive assessment beyond eosinophils in eosinophilic esophagitis: an updated network meta-analysis.
Lyu Y, Wu Z, Zhou Y, Zhang Y, Zhao S. · BMC Gastroenterol · 2025 · cited 0 timesOpen accesssystematic review, review-article
- Validation of the Novel Pediatric Eosinophilic Esophagitis Sign/Symptom Questionnaire-Caregiver Version in EoE KIDS.
Chehade M, McCann E, Spergel J, Yaworsky A, Lamoureux RE, Litcher-Kelly L, Burbridge C, Sutter C, Newton L, Liu R, Tilton ST, Kamat S, Dellon ES. · J Allergy Clin Immunol Pract · 2026 · cited 0 timesclinical trial, phase iii, research support, non-u.s. gov't
- Dupilumab Improves Multiple Aspects of Dysphagia Symptoms in a Randomized Trial of Eosinophilic Esophagitis.
Dellon ES, Chehade M, Schoepfer AM, Liberty EoE Treet Group, Mccann E. · Clin Gastroenterol Hepatol · 2026 · cited 1 timesrandomized controlled trial
- The Association of Inflammatory Bowel Disease and Eosinophilic Esophagitis: A Systematic Review and Meta-analysis.
Yanofsky R, Jogendran R, Hoxha T, Pathak A, Orchanian-Cheff A, Chhibba T, Sasson AN, Tandon P. · Inflamm Bowel Dis · 2025 · cited 4 timesOpen accessmeta-analysis, systematic review
- A Systematic Review and Meta-Analysis on the Induction of Confirmed Eosinophilic Esophagitis as a Side Effect of Allergen Immunotherapy: An EAACI Task Force Report.
Rossi CM, Terreehorst I, Apostolidou E, Votto M, Bakirtas A, Cianferroni A, Konstantinou GN, Pantavou K, Antolin-Amerigo D, Heffler E, Alvarez-Perea A, Fernandez-Rivas M, Nikolopoulos GK, Pfaar O, Pitsios C. · Allergy · 2026 · cited 6 timesOpen accessmeta-analysis, systematic review
- Cendakimab (anti-IL-13) administration improves esophageal gene expression in eosinophilic esophagitis.
Caldwell JM, Ballaban AY, Li J, Maddux R, Harris S, Dellon ES, Rothenberg ME. · J Allergy Clin Immunol · 2026 · cited 8 timesclinical trial, phase ii, research support, non-u.s. gov't
- Real-world Effectiveness of Dupilumab in Eosinophilic Esophagitis: A Systematic Review and Meta-analysis.
Garg A, Moond V, Velpari S, Broder A, Mohan BP. · J Clin Gastroenterol · 2025 · cited 4 timesmeta-analysis, systematic review
- Advances in diagnostic techniques for eosinophilic esophagitis: a systematic review of emerging noninvasive methods.
Al Abdulqader AK. · Eur J Med Res · 2025 · cited 2 timesOpen accesssystematic review, review-article
- Effect of Budesonide Oral Suspension on Time to First Dysphagia Symptom Response and Dysphagia Symptom Resolution Outcomes in Patients With Eosinophilic Esophagitis.
Dellon ES, Katzka DA, Mukkada VA, Falk GW, Tahir MJ, Gugiu PC, Blau J, Terreri B. · J Gastroenterol Hepatol · 2026 · cited 1 timesOpen accessrandomized controlled trial
- Non-invasive biomarkers to diagnose and monitor eosinophilic esophagitis: a systematic review.
Noble SL, Tyrrell R, Mules TC, Inns S. · Front Med (Lausanne) · 2025 · cited 4 timesOpen accesssystematic review, systematic-review
- Open-Label, Phase 2a Pilot Study Evaluating the Efficacy and Tolerability of Topical Mesalamine Treatment in Adult Patients With Active Eosinophilic Esophagitis.
Greuter T, Straumann A, Kreienbühl A, Burrack S, Mueller R, Biedermann L. · Clin Gastroenterol Hepatol · 2026 · cited 0 timesclinical trial, phase ii
- Dupilumab Efficacy in Children With Eosinophilic Esophagitis With Prior Swallowed Topical Corticosteroid Use: A Subgroup Analysis.
Chehade M, Oliva S, Ashok D, Liu R, Maloney J, Abdulai RM, Louisias M, Radin A. · Am J Gastroenterol · 2026 · cited 1 timesOpen accessclinical trial, phase iii, multicenter study
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.